Literature DB >> 17936207

Stem cell therapy for vascular disease.

Benjamin Adams1, Qingzhong Xiao, Qingbo Xu.   

Abstract

Endothelial dysfunction/loss is a key event in the development of vascular diseases, including native atherosclerosis, angioplasty-induced restenosis, transplant arteriosclerosis, and vein bypass graft atherosclerosis. In challenge to the traditional concept that lost endothelial cells were replaced by neighboring endothelial replication, recent studies have shown that stem cells in blood and the vessel wall have the ability to repair endothelial cells after extensive loss. Concomitantly, accumulating data indicate that stem cell therapy is a promising option for the treatment of vascular diseases and might, in the future, contribute to tissue regeneration, that is, the restoration of endothelium lining the arteries to recover the function of the vascular system. In the present review, we will focus on the progress of stem cell therapy, discuss the mechanisms of stem cell differentiation into endothelial cells, and point out the clinical potential of stem cell therapy in the future.

Entities:  

Mesh:

Year:  2007        PMID: 17936207     DOI: 10.1016/j.tcm.2007.08.005

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  12 in total

1.  Endothelial differentiation of adipose-derived stem cells from elderly patients with cardiovascular disease.

Authors:  Ping Zhang; Neil Moudgill; Eric Hager; Nicolas Tarola; Christopher Dimatteo; Stephen McIlhenny; Thomas Tulenko; Paul J DiMuzio
Journal:  Stem Cells Dev       Date:  2010-11-01       Impact factor: 3.272

2.  The source of neointimal cells in vein grafts: does the origin matter?

Authors:  Heleen Rienstra; Clark J Zeebregts; Jan-Luuk Hillebrands
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

Review 3.  Stem Cell Sources and Graft Material for Vascular Tissue Engineering.

Authors:  Dorothee Hielscher; Constanze Kaebisch; Benedikt Julius Valentin Braun; Kevin Gray; Edda Tobiasch
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

Review 4.  Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells.

Authors:  Nicholas J Leeper; Arwen L Hunter; John P Cooke
Journal:  Circulation       Date:  2010-08-03       Impact factor: 29.690

Review 5.  Smooth muscle cell differentiation in vitro: models and underlying molecular mechanisms.

Authors:  Changqing Xie; Raquel P Ritchie; Huarong Huang; Jifeng Zhang; Y Eugene Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

Review 6.  Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease.

Authors:  Geoffrey O Ouma; Rebecca A Jonas; M Haris U Usman; Emile R Mohler
Journal:  Vasc Med       Date:  2012-04-11       Impact factor: 3.239

Review 7.  Endothelial cells derived from nuclear reprogramming.

Authors:  Wing Tak Wong; Ngan F Huang; Crystal M Botham; Nazish Sayed; John P Cooke
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

8.  Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuli.

Authors:  Ping Zhang; Jason Baxter; Kateki Vinod; Thomas N Tulenko; Paul J Di Muzio
Journal:  Stem Cells Dev       Date:  2009-11       Impact factor: 3.272

9.  Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat.

Authors:  Grégory Lacraz; Marie-Hélène Giroix; Nadim Kassis; Josiane Coulaud; Anne Galinier; Christophe Noll; Mélanie Cornut; Fabien Schmidlin; Jean-Louis Paul; Nathalie Janel; Jean-Claude Irminger; Micheline Kergoat; Bernard Portha; Marc Y Donath; Jan A Ehses; Françoise Homo-Delarche
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

Review 10.  The role of progenitor cells in the development of intimal hyperplasia.

Authors:  Shirling Tsai; Jason Butler; Shahin Rafii; Bo Liu; K Craig Kent
Journal:  J Vasc Surg       Date:  2008-10-22       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.